IDEX Corporation IEX
Verdict: Sell. Fair value $114 against a price of $181 on 6 Jan 2026, 37% below the price.
In plain words
The case for: Narrow competitive moat provides durability. Industry tailwinds with growing market.
The case against: Macro headwinds could impact growth. Valuation multiple compression risk.
Main risks
- Stagnating Revenue Growth: Latest annual revenue growth was 0.0%, a sharp deceleration from the 3-year CAGR of 5.8%, indicating a potential slowdown in core markets.
- Deteriorating Profitability: Annual Net Income declined 15% from $0.60B to $0.51B on flat revenue, signaling significant margin pressure.
- Poor Returns on Invested Capital: ROIC of ~7.8% and a 3-year ROIIC of ~7.4% are weak. These returns are likely below the company's cost of capital, suggesting that recent investments are not generating sufficient value for shareholders.
- Valuation prices in optimistic scenario (limited margin for error)
- Overhang: The primary overhang stems from 'persisting headwinds' and market concerns regarding 'ques...
- Market volatility